Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations

Biomaterials

Volumn 53, Issue , 2015, Pages 646-658

  Gao, Xiang ^a   Wang, Shimin ^a   Wang, BiLan ^a   Deng, Senyi ^a   Liu, Xiaoxiao ^a   Zhang, XiaoNing ^b   Luo, LinLi ^a   Fan, RangRang ^a   Xiang, MingLi ^a   You, Chao ^a   Wei, YuQuan ^a   Qian, ZhiYong ^a   Guo, Gang ^a  

^a SICHUAN UNIVERSITY   (China)

^b Tsinghua University   (China)

Author keywords

Cell apoptosis; Cell growth; Docetaxel; MPEG PCL; Ovarian cancer; Self assembly

Indexed keywords

BIOCOMPATIBILITY; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED DRUG DELIVERY; DISEASES; DRUG PRODUCTS; GROWTH KINETICS; POLYETHYLENE GLYCOLS; SELF ASSEMBLY; TARGETED DRUG DELIVERY; TUMORS;

CELL APOPTOSIS; CLINICAL APPLICATION; DOCETAXEL; ENCAPSULATION EFFICIENCY; IMMUNOHISTOCHEMICAL ANALYSIS; METHOXYPOLYETHYLENE GLYCOL; MPEG-PCL; OVARIAN CANCERS;

MICELLES;

COUMARIN; DIMETHYL SULFOXIDE; DOCETAXEL; DRUG CARRIER; METHOXY POLY(ETHYLENE GLYCOL); MICELLE (PHARMACEUTICS); POLYCAPROLACTONE; POLYMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MICELLE; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EXTRAVASATION; DRUG RETENTION; DRUG UPTAKE; EMBRYO; ENCAPSULATION; FEMALE; FLUORESCENCE IMAGING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; ZEBRA FISH; ANIMAL; BAGG ALBINO MOUSE; CELL DIVISION; HUMAN; MICELLE; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; COMPUTER SIMULATION; DRUG CARRIERS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICELLES; OVARIAN NEOPLASMS; TAXOIDS; ZEBRAFISH;

EID: 84927933814     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.108     Document Type: Article

References (55)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2012, 2012(62):10-29.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2013, 2013(1):11-30.
3. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
4. Hunn J., Rodriguez G.C. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 2012, 55:13-23.
5. Sredzińska K., Gajko A., Gałasiński W., Gindzieński A. Effect of the components extracted from the needles of Taxus baccata on protein biosynthesis in a cell-free rat liver system. Acta Pol Pharm 1999, 56:29-33.
6. Mackler N.J., Pienta K.J. Drug insight: use of docetaxel in prostate and urothelial cancers. Nat Clin Pract Urol 2005, 2:92-100.
7. Agarwal R., Kaye S.B. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003, 3:502-516.
8. Vasey P.A., Atkinson R., Coleman R., Crawford M., Cruickshank M., Eggleton P., et al. Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer. Br J Cancer 2001, 84:170-178.
9. Yap T.A., Carden C.P., Kaye S.B. Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer 2009, 9:167-181.
10. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010, 10:194-204.
11. Rath O., Kozielski F. Kinesins and cancer. Nat Rev Cancer 2012, 12:527-539.
12. Schwartz E.L. Antivascular actions of microtubule-binding drugs. Clin Cancer Res 2009, 15:2594-2601.
13. De S., Cipriano R., Jackson M.W., Stark G.R. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells. Cancer Res 2009, 69:8035-8042.
14. Escobar P.F., Rose P.G. Docetaxel in ovarian cancer. Expert Opin Pharmacother 2005, 6:2719-2726.
15. Halder J., Landen C.N., Lutgendorf S.K., Li Y., Jennings N.B., Fan D., et al. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin Cancer Res 2005, 11:8829-8836.
16. Morse D.L., Gray H., Payne C.M., Gillies R.J. Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 2005, 4:1495-1504.
17. Hwang H.Y., Kim I.S., Kwon I.C., Kim Y.H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. JControl Release 2008, 128:23-31.
18. Liu T.Y., Chen S.Y., Liu D.M., Liou S.C. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery. JControl Release 2005, 107:112-121.
19. Kleemann E., Neu M., Jekel N., Fink L., Schmehl T., Gessler T., et al. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. JControl Release 2005, 109:299-316.
20. Xiong X.B., Ma Z., Lai R., Lavasanifar A. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 2010, 31:757-768.
21. Endres T.K., Beck-Broichsitter M., Samsonova O., Renette T., Kissel T.H. Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials 2011, 32:7721-7731.
22. Meng F., Hennink W.E., Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 2009, 30:2180-2198.
23. Huang C.-K., Lo C.-L., Chen H.-H., Hsiue G.-H. Multifunctional micelles for cancer cell targeting, distribution imaging, and anticancer drug delivery. Adv Funct Mater 2007, 17:2291-2297.
24. Lo C.L., Huang C.K., Lin K.M., Hsiue G.H. Mixed micelles formed from graft and diblock copolymers for application in intracellular drug delivery. Biomaterials 2007, 28:1225-1235.
25. Zhang G., Yang Z., Lu W., Zhang R., Huang Q., Tian M., et al. Influence of anchoring ligands and particle size on the colloidal stability and invivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30:1928-1936.
26. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., Gong S. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(l-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Biomaterials 2009, 30:3009-3019.
27. Wu WenChung, Chen ChingYi, Tian Yanqing, Jang SeiHum, Hong Yuning, Liu Yang, et al. Enhancement of aggregation-induced emission in dye-encapsulating polymeric micelles for bioimaging. Adv Funct Mat 2010, 9:1413-1423.
28. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., et al. Multifunctional polymeric micelles as cancer-targeted, mri-ultrasensitive drug delivery systems. Nano Lett 2006, 6:2427-2430.
29. Gou M., Men K., Shi H., Xiang M., Zhang J., Song J., et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy invitro and invivo. Nanoscale 2011, 3:1558-1567.
30. Gong C., Deng S., Wu Q., Xiang M., Wei X., Li L., et al. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 2013, 34:1413-1432.
31. Halgren Thomas A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. JComput Chem 1996, 17:490-519.
32. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. JAm Chem Soc 1985, 107:3902-3909.
33. Fletcher R. Function minimization by conjugate gradients. Comput J 1964, 7:149-154.
34. Gong C., Xie Y., Wu Q., Wang Y., Deng S., Xiong D., et al. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Nanoscale 2012, 4:6004-6017.
35. Brooks B., Bruccoleri R., Olafson B., States D., Swaminathan S., Karplus M.C.H.A.R.M.M. Aprogram for macromolecular energy, minimization, and dynamics calculations. JComput Chem 1983, 4:187-217.
36. Brooks B., Brooks C., Mackerell A., Nilsson L., Petrella F., Roux B., et al. CHARMM: the biomolecular simulation program. JComput Chem 2009, 30:1545-1614.
37. Khatun S. 3D experimental detection and discrimination of malignant and benign breast tumor using NN-based UWB imaging system. Prog Electromag Res 2011, 116:221-237.
38. Khatun S. Experimental breast tumor detection using NN-based UWB imaging. Prog Electromag Res 2011, 111:447-465.
39. Wu Q., Deng S., Li L., Sun L., Yang X., Liu X., et al. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models. Nanoscale 2013, 5:12480-12493.
40. Gao X., Zheng F., Guo G., Liu X., Fan R., Qian Z., et al. Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles. JMater Chem B 2013, 1:5778-5790.
41. Murakami H., Yamanaka T., Seto T., Sugio K., Okamoto I., Sawa T., et al. Aphase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan oncology group. Cancer Sci 2014, 105:989-995.
42. Hendrikx J.J., Hendrikx J., Lagas J.S., Wagenaar E., Rosing H., Schellens J.H., et al. Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation. Br J Cancer 2014, 110:2669-2676.
43. Hendrikx J.J., Lagas J.S., Wagenaar E., Rosing H., Schellens J.H., Beijnen J.H., et al. Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in mcf7 breast cancer cells. Mol Cancer Ther 2014, 13:2092-2103.
44. Napoli A., Valentini M., Tirelli N., Müller M., Hubbell J.A. Oxidation-responsive polymeric vesicles. Nat Mat 2004, 3:183-189.
45. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003, 2:347-360.
46. Meng H., Xue M., Xia T., Ji Z., Tarn D.Y., Zink J.I., et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011, 5:4131-4144.
47. Prabhakar U., Maeda H., Jain R.K., Sevick-Muraca E.M., Zamboni W., Farokhzad O.C., et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 2013, 73:2412-2417.
48. Iyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Disc Today 2006, 11:812-818.
49. Shiraishi K., Hamano M., Ma H., Kawano K., Maitani Y., Aoshi T., et al. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. JControl Release 2013, 165:183-190.
50. Xue B., Wang Y., Tang X., Xie P., Wang Y., Luo F., et al. Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery invitro. JBiomed Nanotechnol 2012, 8:80-89.
51. Ungaro F., Conte C., Ostacolo L., Maglio G., Barbieri A., Arra C., et al. Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and invivo toxicity. Nanomedicine 2012, 8:637-646.
52. Ostacolo L., Marra M., Ungaro F., Zappavigna S., Maglio G., Quaglia F., et al. Invitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: do nanocarrier properties have a role?. JControl Release 2010, 148:255-263.
53. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., et al. Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 2011, 6:815-823.
54. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010, 75:1-18.
55. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14:1310-1316.